Viewing Study NCT07278856


Ignite Creation Date: 2025-12-24 @ 11:36 PM
Ignite Modification Date: 2026-05-15 @ 7:25 AM
Study NCT ID: NCT07278856
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-12
First Post: 2025-11-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas
Sponsor: City of Hope Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Follicular Helper T-Cell Lymphoma View
None Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type View
None Follicular Helper T-Cell Lymphoma, Follicular-Type View
None Follicular Helper T-Cell Lymphoma, Not Otherwise Specified View
None Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma View
None Peripheral T-Cell Lymphoma, Not Otherwise Specified View
Keywords: